Science & Enterprise subscription

Follow us on Twitter

  • A biomedical engineering lab and analytics company are testing the feasibility of algorithms to find early signs of… https://t.co/KRVGnVRxpC
    about 7 hours ago
  • New post on Science and Enterprise: Study Testing Wearables Data for Covid-19 Clues https://t.co/Ybk48QXn0U #Science #Business
    about 7 hours ago
  • The developer of an antibody cocktail to treat non-hospitalized Covid-19 patients released first results from a cli… https://t.co/YGxzmClqvT
    about 15 hours ago
  • New post on Science and Enterprise: Mixed Early Results in Covid-19 Antibody Cocktail Trial https://t.co/riNupxXBki #Science #Business
    about 15 hours ago
  • A new enterprise is creating thin films for vaccines, including Covid-19, to make possible their mass production an… https://t.co/gPWJ3Rm9Vm
    about 1 day ago

Please share Science & Enterprise

Infographic – Mental Health Effects of Pandemic

Covid-19 and mental health chart

Physical symptoms experienced by people with Covid-19 infections are well documented over the past few months, but the psychological toll is also beginning to get attention. . . . → Read More: Infographic – Mental Health Effects of Pandemic

Advanced Solid Tumor Precision Meds. Trial Begins

Brain tumor graphic

A clinical trial is underway testing a treatment for advanced-stage cancers that blocks amino acids allowing nutrients to feed the growth of solid tumors. . . . → Read More: Advanced Solid Tumor Precision Meds. Trial Begins

Biotech IDs Potent Covid-19 Antibodies

SARS-Cov-2 virus

A company discovering therapeutic antibodies identified antibodies considered particularly effective in neutralizing SARS-CoV-2 viruses causing Covid-19 infections. . . . → Read More: Biotech IDs Potent Covid-19 Antibodies

Drug Maker Licenses Low-Dose Vaccine Patch

Nanopatch system

The pharmaceutical company Merck is licensing a microneedle patch device that delivers vaccines with a small fraction of the dose normally needed by syringes. . . . → Read More: Drug Maker Licenses Low-Dose Vaccine Patch

TB Vaccine Test on Covid-19 Expanding to Europe

SARS-Cov-2 virus

A clinical trial testing a current tuberculosis vaccine among health care workers in Australia is expanding in that country and to two European countries. . . . → Read More: TB Vaccine Test on Covid-19 Expanding to Europe

Case Study Maps Covid-19 Immune Response

Coronavirus

Infectious disease specialists in Australia tracked the course of an early patient’s immune-system response to non-severe novel coronavirus, or Covid-19, infections. . . . → Read More: Case Study Maps Covid-19 Immune Response

Patch Delivers Low-Dose Vaccine with Full-Dose Power

Influenza virus

A clinical trial shows a polymer patch with one-sixth of the usual influenza vaccine dose generates about the same immune reaction as a full-dose injection. . . . → Read More: Patch Delivers Low-Dose Vaccine with Full-Dose Power

Intl Group Calls for More Coronavirus Vaccines

Hong Kong residents in masks

An international consortium issued a proposal call for more vaccines to protect against the novel coronavirus now spreading from China to the rest of the world. . . . → Read More: Intl Group Calls for More Coronavirus Vaccines

Stem Cell Transplants Offer Nerve Pain Relief

Researchers in Australia show in tests with lab mice that transplanted adult stem cells can provide long-term relief from chronic pain caused by nerve damage. . . . → Read More: Stem Cell Transplants Offer Nerve Pain Relief

Int’l Group Funding Coronavirus Vaccines

Health screening Shanghai

An international health coalition is funding development of vaccines against the new coronavirus outbreak spreading quickly through China and to other countries. . . . → Read More: Int’l Group Funding Coronavirus Vaccines